Your browser doesn't support javascript.
loading
Efficacy and safety of abatacept in active primary Sjögren's syndrome: results of a phase III, randomised, placebo-controlled trial.
Baer, Alan N; Gottenberg, Jacques-Eric; St Clair, E William; Sumida, Takayuki; Takeuchi, Tsutomu; Seror, Raphaèle; Foulks, Gary; Nys, Marleen; Mukherjee, Sumanta; Wong, Robert; Ray, Neelanjana; Bootsma, Hendrika.
  • Baer AN; Division of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA alanbaer@jhmi.edu.
  • Gottenberg JE; Department of Rheumatology, Strasbourg University Hospitals, National Reference Center for Rare Systemic Autoimmune Diseases, IBMC, CNRS, UPR3572, Strasbourg, France.
  • St Clair EW; Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
  • Sumida T; Department of Internal Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
  • Takeuchi T; Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Seror R; Department of Rheumatology and National Reference Center for Sjögren Syndrome and Rare Autoimmune Diseases, AP-HP Université Paris-Saclay, INSERM UMR1184, Le Kremlin Bicêtre, Paris, France.
  • Foulks G; Department of Ophthalmology and Visual Sciences, University of Louisville School of Medicine, Louisville, Kentucky, USA.
  • Nys M; Global Biometric Sciences, Bristol Myers Squibb, Braine L'Alleud, Belgium.
  • Mukherjee S; Innovative Medicines and Development - Clinical Biomarkers, Bristol Myers Squibb Company, Princeton, New Jersey, USA.
  • Wong R; Immunology and Fibrosis, Bristol Myers Squibb Company, Princeton, New Jersey, USA.
  • Ray N; Global Drug Development - Immunology, Bristol Myers Squibb Company, Princeton, New Jersey, USA.
  • Bootsma H; Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Ann Rheum Dis ; 80(3): 339-348, 2021 03.
Article en En | MEDLINE | ID: mdl-33168545

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndrome de Sjögren Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndrome de Sjögren Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article